Lüdeke I, Terheyden P, Grisanti S, Lüke M (2016) Entwicklung einer serösen Retinopathie unter Behandlung eines metastasierten kutanen Melanoms. Ophthalmologe 113: 861-863
Lüke J, Vukoja V, Brandenbusch T, Nassar K, Rohrbach JM, Grisanti S, Lüke M, Tura A (2016) CD147 and matrix-metalloproteinase-2 expression in metastatic and non-metastatic uveal melanoma. BMC Ophthalmol 16: 74
Maziani B, Baumgarten S, Schiller P, Agostini H, Helbig H, Limburg E, Hellmich M, Walter P, Grisanti S; VIPER Study Group (2016) Vitrectomy with or without encircling band for pseudophakic retinal detachment: a multi-centre, three-arm, randomised clinical trial. VIPER Study Report No. 1. Br J Ophthalmol 100: 405-10
Neubauer AS, Ranjbar M (2016) Low-voltage X-ray combined with anti-VEGF therapy in the treatment of neovascular AMD. Ophthalmology Management iss. 89, 2016
Ranjbar M, Brinkmann MP, Zapf D, Miura Y, Rudolf M, Grisanti S (2016) Fc receptor inhibition reduces susceptibility to oxidative stress in human RPE cells treated with beacizumab, but not aflibercept. Cell Physiol Biochem 38: 737-747
Ranjbar M, Brinkmann MP, Tura A, Rudolf M, Miura Y, Grisanti S (2016) Ranibizumab interacts with the VEGF-A/VEGFR-2 signaling pathway in human RPE cells at different levels. Cytokine 83: 210-16
Ranjbar M, Mohi A, Pföhler C, Grisanti S, Rudolf M (2016) Introducing MARCo: Histoserological findings of a multi-organic paraneoplastic syndrome in cutaneous melanoma patients. Dermatol Ther (epub)
Stenzel M, Tura A, Nassar K, Rohrbach JM, Grisanti S, Lüke M, Lüke J (2016) Analysis of Caveolin-1 and Phosphoinositol-3 Kinase expression in primary uveal melanoma. Clin Exp Ophthalmol 44: 400-9
Ranjbar M, Kurz M, Holzhey A, Melchert C, Rades D, Grisanti S (2016) Stereotactic radiotherapy in neovascular age-related macular degeneration. Real-life efficay and morphological evaluation of the outer retina-choroid complex. Medicine 95 (52) e5729
Ranjbar M, Schneider T, Brand C, Grisanti S, Lüke J, Lüke M (2016) The effect of anakrina on retinal function. Iranian Society Ophthalmol (in press)
Stenzel M, Tura A, Nassar K, Rohrbach JM, Grisanti S, Lüke M, Lüke J (2016) Analysis of Caveolin-1 and Phosphoinosital-3 kinase expression in primary uveal melanoma. Clin Exp Ophthalmol 44: 400-0
Tura A, Merz H, Reinsberg M, Lüke M, Jager MJ, Grisanti S, Lüke J (2016) Analysis of monosomy-3 in immunomagnetically isolated circulating melanoma cells in uveal melanoma cells. Pigment Cell Melanoma Res 29: 583-9
Tura A, Alt A, Lüke J, Grisanti S, Haritoglu C, Meyer CH, Nassar K, Lüke M (2016) Biocompatibility of the vital dye Acid Violet-17 on retinal pigment epithelial cells. Clin Ophthalmol 10: 1435-45
Vukoja V, Brandenbusch T, Tura A, Nassar K, Rohrbach JM, Lüke M, Grisanti S, Lüke J (2016) Expression von EphA2 in metastasierten und nicht-metastasierten primären uvealen Melanomen. Klin Monatsbl Augenheilkd 232: 290-7
Walter P, Hellmich M, Baumgarten S, Schiller P, Limburg E, Agostini H, Pielen A, Helbig H, Lommatzsch A, Rössler G, Maziani B; VIPER Study Group (2016) Vitrectomy with and without encircling band for pseudophacic retinal detachment: VIPER Study Report No 2 - main results. Br J Ophthalmol 2016